CTRI/2022/11/047243
Active, not recruiting
Phase 2
Pharmaceutical, analytical, safety evaluation and clinical study of kasaghna dhooma varti in kasa chikitsa.
GOVERNMENT AYURVEDIC COLLEGE AND HOSPITA0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: J00- Acute nasopharyngitis [common cold]
- Sponsor
- GOVERNMENT AYURVEDIC COLLEGE AND HOSPITA
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients having clinical sign and symptoms of
- •2\. Patients with in the age group of 18 to 60 year old MF .
Exclusion Criteria
- •1\.Patients suffering from chronic disease of lung,
- •COPD ,CA lung ,
- •2\. K\|C of Bronchial Asthma
- •3\. Patients of HTN and Cardiac problem.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Pharmaceutico analytical and clinical study of Herbo mineral compound along with Herbal formulation in the management of agni mandya (Thyroid disorder)Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidismCTRI/2023/09/057743ATIONAL INSTITUTE OF AYURVEDA
Not yet recruiting
Phase 1
To see the effect of Taruniyapidikahar lepa in Acne vulgarisCTRI/2023/08/056329ttarakhand Ayurved University
Not yet recruiting
Phase 2
Study of Gojihwadi kwatha in the management of BronchitisCTRI/2020/09/028118ational Institute of Ayurveda
Not yet recruiting
Phase 1
Effect of Arka Taila and Its Cream In VicharchikaHealth Condition 1: L209- Atopic dermatitis, unspecifiedCTRI/2020/08/027269ational Institute of Ayurveda
Active, not recruiting
Not Applicable
Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer'sDisease or Mild Alzheimer's DiseaseEUCTR2011-005217-37-ITELI LILLY AND COMPANY260